Comparison of patients using lamivudine, entecavir, and tenofovir according to liver fibrosis markers fibrosis-4 and aspartate aminotransferase-to-platelet ratio index scores.

Okan, Huseyin Dogus; Karabay, Oguz; Guclu, Ertugrul; Inci, Mustafa Baran; Ogutlu, Aziz

Okan, Huseyin Dogus; Karabay, Oguz; Guclu, Ertugrul; Inci, Mustafa Baran; Ogutlu, Aziz.

Afiliação

Okan HD; Department of Infectious Diseases and Clinic Microbiology, Sakarya University, Faculty of Medicine, Sakarya, Turkey.
Karabay O; Department of Infectious Diseases and Clinic Microbiology, Sakarya University, Faculty of Medicine, Sakarya, Turkey.
Guclu E; Department of Infectious Diseases and Clinic Microbiology, Sakarya University, Faculty of Medicine, Sakarya, Turkey.
Inci MB; Department of Public Health, Sakarya University, Faculty of Medicine, Sakarya, Turkey.
Ogutlu A; Department of Infectious Diseases and Clinic Microbiology, Sakarya University, Faculty of Medicine, Sakarya, Turkey.

Indian J Pharmacol ; 55(1): 14-20, 2023.

Article em En | MEDLINE | ID: mdl-36960516

Assuntos

Hepatite B Crônica; Lamivudina; Humanos; Tenofovir/uso terapêutico; Lamivudina/uso terapêutico; Antivirais/uso terapêutico; Hepatite B Crônica/tratamento farmacológico; Antígenos E da Hepatite B/uso terapêutico; Estudos Retrospectivos; Cirrose Hepática/tratamento farmacológico; Fibrose; Aspartato Aminotransferases; Resultado do Tratamento

Palavras-chave

Aspartate aminotransferase-to-platelet ratio index; fibrosis-4; hepatitis B

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lamivudina / Hepatite B Crônica Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Indian J Pharmacol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google